RNS Number:6187N
ReGen Therapeutics PLC
16 July 2003


16 July 2003

ReGen Therapeutics Plc


DIRECTOR'S SHAREHOLDING

London, UK - 16 July, 2003:  ReGen Therapeutics Plc (the "Company") a company
developing a treatment for Alzheimer's Disease has today received notification
from Percy Lomax the Executive Chairman that he has subscribed for 333,333 new
ordinary shares in the placing announced on the 15 July 2003 at 1.5p per new
ordinary share.  This will bring his total holding in the Company to 1,782,069
ordinary shares representing 0.79 per cent of the company's issued share capital
following the placing.



For further information, please contact:

Andrew Marshall
Marshall Robinson Roe
Tel No 020 7489 2033

 

                     This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSEAAXKFASDEFE